• Joaquim Mullol, Isam Alobid, Franklin Mariño-Sánchez, Adriana Izquierdo-Domínguez, Concepció Marin, Ludger Klimek, De-Yun Wang, and Zheng Liu.
• Rhinology Unit & Smell Clinic, ENT Department, Hospital Clinic Barcelona, Barcelona, Catalonia, Spain. jmullol@clinic.cat.
• Curr Allergy Asthma Rep. 2020 Aug 3; 20 (10): 61.

Purpose Of ReviewOlfactory dysfunction in upper airway viral infections (common cold, acute rhinosinusitis) is common (> 60%). During the COVID-19 outbreak, frequency of sensory disorders (smell and/or taste) in affected patients has shown a high variability from 5 to 98%, depending on the methodology, country, and study.Recent FindingsA sudden, severe, isolated loss of smell and/or taste, in the absence of other upper airway inflammatory diseases (allergic rhinitis, chronic rhinosinusitis, nasal polyposis), should alert individuals and physicians on being potentially affected by COVID-19. The evaluation of smell/taste disorders with a visual analogue scale or an individual olfactory or gustatory test, at the hospital or by telemedicine, to prevent contamination might facilitate an early detection of infected patients and reduce the transmission of SARS-CoV-2. During the COVID-19 outbreak, patients with sudden loss of smell should initiate social distancing and home isolation measures and be tested for SARS-CoV-2 diagnostic test when available. Olfactory training is recommended when smell does not come back after 1 month but can be started earlier.

28 keywords...

hide…